Inceptor Bio
Advancing Cell and Gene Therapies to Cure Cancer
28 employees · est. 2020 · Morrisville, United States
T Cell Nouveau
Clinical stage biopharmaceutical company with novel TCR like CAR-T cell therapy for solid tumors at affordable price
1 employees · est. 2021 · Tokyo, Japan
Inceptor Bio is the older company (2020 vs 2021); Inceptor Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Inceptor Bio | T Cell Nouveau |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2021 |
| Headquarters | ||
| Headquarters | Morrisville, United States | Tokyo, Japan |
| Employees | ||
| Employees | 28 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Debt Financing | Not tracked yet |
| Total Funding | ||
| Total Funding | $87.65M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 5 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Gene Therapy, Cancer Treatment, Immunotherapy, Tumor Microenvironment, Oncology, Cancer Research, Immune Cell Performance, Novel Mechanisms, Next-generation Therapies | Biopharmaceutical Company, TCR-T Cell Therapy, CAR-T Cell Therapy, Immunotherapy, Solid Tumors, Oncoimmunotherapy, Oncology, Cell Therapy, Cancer Therapy, Neoantigen, MAGEA4, PRAME, Head And Neck Cancer, HLA02, Cancer Vaccine |
| Website | ||
| Website | inceptor.bio | tcellnouveau.com |
About Inceptor Bio
Inceptor Bio is a biotechnology startup, founded in 2020, headquartered in the United States. The company's slogan, "Advancing Cell and Gene Therapies to Cure Cancer," reflects its mission to develop next-generation cell therapy platforms aimed at curing difficult-to-treat cancers. Inceptor Bio's fo...
About T Cell Nouveau
T Cell Nouveau is a clinical stage biopharmaceutical company based in Japan that aims to revolutionize cancer treatment. Their mission is to provide affordable TCR like CAR-T cell therapies for common cancers, making it accessible to common people. The company's proprietary technology, originating f...
We will tell you when either one moves
BounceWatch watches Inceptor Bio and T Cell Nouveau for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Inceptor Bio and T Cell Nouveau — by email.
Frequently Asked Questions
Compare Inceptor Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Inceptor Bio on 11 Sep 2024, and T Cell Nouveau on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
